| Insideraktier | 21.163.230 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Argos Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ARGS / Argos Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ARGS / Argos Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-04-25 | 2018-04-25 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | -27.150 | 20.056 | ||||||
| 2018-04-25 | 2018-04-25 | 4 | Harrelson Lori R. | ARGS | Common Stock | D | -22.629 | 11.776 | ||||||
| 2018-04-25 | 2018-04-25 | 4 | Katz Richard D | ARGS | Common Stock | D | -22.629 | 9.697 | ||||||
| 2018-04-25 | 2018-04-25 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | -67.887 | 25.450 | ||||||
| 2018-04-02 | 2018-03-28 | 4 | Katz Richard D | ARGS | Common Stock | D | 22.629 | 32.326 | ||||||
| 2018-03-30 | 2018-03-28 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 67.887 | 93.337 | ||||||
| 2018-03-30 | 2018-03-28 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | 27.150 | 47.206 | ||||||
| 2018-03-30 | 2018-03-28 | 4 | Harrelson Lori R. | ARGS | Common Stock | D | 22.629 | 34.405 | ||||||
| 2018-01-12 | 2018-01-10 | 4/A | Abbey Jeffrey D | ARGS | Common Stock | D | 0,1646 | -124.987 | -21 | 510.046 | ||||
| 2018-01-12 | 2018-01-10 | 4/A | Harrelson Lori R. | ARGS | Common Stock | D | 0,1647 | -64.329 | -11 | 230.981 | ||||
| 2018-01-12 | 2018-01-10 | 4/A | Nicolette Charles A. | ARGS | Common Stock | D | 0,1646 | -100.250 | -17 | 399.990 | ||||
| 2018-01-12 | 2018-01-10 | 4/A | Katz Richard D | ARGS | Common Stock | D | 0,1647 | -104.435 | -17 | 193.959 | ||||
| 2018-01-12 | 2018-01-09 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 0,1646 | -124.987 | -21 | 510.046 | ||||
| 2018-01-12 | 2018-01-09 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | 0,1646 | -100.250 | -17 | 399.990 | ||||
| 2018-01-12 | 2018-01-09 | 4 | Harrelson Lori R. | ARGS | Common Stock | D | 0,1647 | -64.329 | -11 | 230.981 | ||||
| 2018-01-12 | 2018-01-09 | 4 | Katz Richard D | ARGS | Common Stock | D | 0,1647 | -104.435 | -17 | 193.959 | ||||
| 2018-01-05 | 2018-01-03 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 0,1632 | -114.702 | -19 | 635.033 | ||||
| 2018-01-05 | 2018-01-03 | 4 | Harrelson Lori R. | ARGS | Common Stock | D | 0,1635 | -59.072 | -10 | 295.310 | ||||
| 2018-01-05 | 2018-01-03 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | 0,1637 | -92.001 | -15 | 500.240 | ||||
| 2018-01-05 | 2018-01-03 | 4 | Katz Richard D | ARGS | Common Stock | D | 0,1634 | -101.228 | -17 | 298.394 | ||||
| 2018-01-05 | 2018-01-03 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 0,1632 | -114.702 | -19 | 635.033 | ||||
| 2017-11-02 | 2017-10-31 | 4 | Pharmstandard International S.A. Pharmstandard International S.A. is a wholly owned subsidiary of Joint Stock Company Pharmstandard. | ARGS | Common Stock | I | 795,9600 | -99.495 | -79.194 | 13.142.784 | ||||
| 2017-09-28 | 2017-09-26 | 4 | MORRISON RICHARD G | ARGS | Stock Option (right to buy) | D | 0,17 | 30.000 | 30.000 | |||||
| 2017-08-31 | 2017-08-30 | 4 | Harrelson Lori R. | ARGS | Common Stock | D | 320.683 | 354.382 | ||||||
| 2017-08-31 | 2017-08-30 | 4 | Katz Richard D | ARGS | Common Stock | D | 395.664 | 399.622 | ||||||
| 2017-08-31 | 2017-08-30 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | 499.445 | 592.241 | ||||||
| 2017-08-31 | 2017-08-30 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 622.685 | 749.735 | ||||||
| 2017-06-23 | 2017-06-21 | 4 | Pharmstandard International S.A. | ARGS | Convertible Secured Promissory Note | I | 0,50 | |||||||
| 2017-01-23 | 2017-01-19 | 4 | Katz Richard D | ARGS | Stock Option (right to buy) | D | 4,85 | 105.000 | 105.000 | |||||
| 2017-01-23 | 2017-01-19 | 4 | Katz Richard D | ARGS | Common Stock | D | 3.958 | 3.958 | ||||||
| 2017-01-23 | 2017-01-19 | 4 | ALLEN LEE F MD PhD | ARGS | Stock Option (right to buy) | D | 4,85 | 85.000 | 85.000 | |||||
| 2017-01-23 | 2017-01-19 | 4 | ALLEN LEE F MD PhD | ARGS | Common Stock | D | 7.378 | 7.378 | ||||||
| 2017-01-23 | 2017-01-20 | 4 | Harrelson Lori R. | ARGS | Stock Option (right to buy) | D | 5,05 | 50.000 | 50.000 | |||||
| 2017-01-23 | 2017-01-20 | 4 | Harrelson Lori R. | ARGS | Common Stock | D | 3.694 | 33.699 | ||||||
| 2017-01-23 | 2017-01-19 | 4 | Abbey Jeffrey D | ARGS | Stock Option (right to buy) | D | 4,85 | 386.212 | 386.212 | |||||
| 2017-01-23 | 2017-01-19 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 17.430 | 127.050 | ||||||
| 2017-01-23 | 2017-01-19 | 4 | Nicolette Charles A. | ARGS | Stock Option (right to buy) | D | 4,85 | 185.000 | 185.000 | |||||
| 2017-01-23 | 2017-01-19 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | 16.753 | 92.796 | ||||||
| 2017-01-23 | 2017-01-19 | 4 | Winterbottom Joan | ARGS | Stock Option (right to buy) | D | 4,85 | 85.000 | 85.000 | |||||
| 2017-01-23 | 2017-01-19 | 4 | Winterbottom Joan | ARGS | Common Stock | D | 4.464 | 47.248 | ||||||
| 2017-01-20 | 2017-01-19 | 4 | Birner Hubert | ARGS | Stock Option (right to buy) | D | 4,85 | 9.500 | 9.500 | |||||
| 2017-01-20 | 2017-01-19 | 4 | van Deventer Sander | ARGS | Stock Option (right to buy) | D | 4,85 | 9.500 | 9.500 | |||||
| 2017-01-20 | 2017-01-19 | 4 | Carey Robert | ARGS | Stock Option (right to buy) | D | 4,85 | 9.500 | 9.500 | |||||
| 2017-01-20 | 2017-01-19 | 4 | Krol Igor | ARGS | Stock Option (right to buy) | D | 4,85 | 9.500 | 9.500 | |||||
| 2017-01-04 | 2016-12-31 | 4 | SNYDERMAN RALPH | ARGS | Common Stock | D | 573 | 573 | ||||||
| 2017-01-04 | 2016-12-31 | 4 | Birner Hubert | ARGS | Common Stock | D | 3.571 | 12.680 | ||||||
| 2017-01-04 | 2016-12-31 | 4 | Carey Robert | ARGS | Common Stock | D | 2.351 | 8.206 | ||||||
| 2017-01-04 | 2016-12-31 | 4 | Krol Igor | ARGS | Common Stock | D | 1.785 | 3.874 | ||||||
| 2017-01-04 | 2016-12-31 | 4 | Mtibelishvily Irackly | ARGS | Common Stock | D | 395 | 14.895 | ||||||
| 2016-12-15 | 3 | Mtibelishvily Irackly | ARGS | Common Stock | D | 29.000 | ||||||||
| 2016-12-15 | 3 | Mtibelishvily Irackly | ARGS | Common Stock | D | 29.000 | ||||||||
| 2016-12-15 | 2016-12-13 | 4 | Mtibelishvily Irackly | ARGS | Stock Option (right to buy) | D | 4,60 | 30.000 | 30.000 | |||||
| 2016-12-13 | 2016-12-09 | 4 | SNYDERMAN RALPH | ARGS | Stock Option (right to buy) | D | 4,90 | 30.000 | 30.000 | |||||
| 2016-10-13 | 2016-10-07 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,7300 | 21.000 | 99 | 13.242.279 | ||||
| 2016-10-13 | 2016-10-06 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,8100 | 2.640 | 13 | 13.221.279 | ||||
| 2016-10-13 | 2016-10-05 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,8500 | 900 | 4 | 13.218.639 | ||||
| 2016-10-13 | 2016-10-04 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,6900 | 7.164 | 34 | 13.217.739 | ||||
| 2016-10-04 | 2016-10-03 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,7000 | 11.308 | 53 | 13.210.875 | ||||
| 2016-10-04 | 2016-09-30 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,7100 | 30.232 | 142 | 13.199.567 | ||||
| 2016-10-03 | 2016-09-30 | 4 | Birner Hubert | ARGS | Common Stock | D | 3.521 | 9.109 | ||||||
| 2016-10-03 | 2016-09-30 | 4 | van Deventer Sander | ARGS | Common Stock | D | 2.263 | 5.057 | ||||||
| 2016-10-03 | 2016-09-30 | 4 | Petrov Andrei Vladimirovich | ARGS | Common Stock | D | 2.137 | 10.530 | ||||||
| 2016-10-03 | 2016-09-30 | 4 | Carey Robert | ARGS | Common Stock | D | 2.263 | 5.855 | ||||||
| 2016-10-03 | 2016-09-30 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 2.263 | 50.955 | ||||||
| 2016-10-03 | 2016-09-30 | 4 | Krol Igor | ARGS | Common Stock | D | 1.760 | 2.089 | ||||||
| 2016-09-30 | 2016-09-29 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,6000 | 15.100 | 69 | 13.169.335 | ||||
| 2016-09-30 | 2016-09-28 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,5400 | 28.518 | 129 | 13.154.235 | ||||
| 2016-09-21 | 2016-09-20 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,7700 | 41.259 | 197 | 13.125.717 | ||||
| 2016-09-21 | 2016-09-19 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,7600 | 5.580 | 27 | 13.084.458 | ||||
| 2016-09-20 | 2016-09-16 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,7800 | 36.632 | 175 | 13.078.578 | ||||
| 2016-09-20 | 2016-09-15 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,7600 | 15.880 | 76 | 13.041.946 | ||||
| 2016-09-07 | 2016-09-01 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,7800 | 16.977 | 81 | 13.026.066 | ||||
| 2016-08-29 | 2016-08-24 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,5700 | 55.224 | 252 | 13.009.089 | ||||
| 2016-08-25 | 2016-08-24 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,5500 | 57.772 | 263 | 12.953.865 | ||||
| 2016-08-25 | 2016-08-23 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,3600 | 9.599 | 42 | 12.896.093 | ||||
| 2016-08-23 | 2016-08-22 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,2600 | 21.950 | 94 | 12.886.494 | ||||
| 2016-08-23 | 2016-08-19 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4,2300 | 53.524 | 226 | 12.864.544 | ||||
| 2016-08-04 | 2016-08-02 | 4 | van Deventer Sander See footnotes | ARGS | Common Stock Warrants (right to buy) | I | 5,50 | 1.159.090 | 1.159.090 | |||||
| 2016-08-04 | 2016-08-02 | 4 | van Deventer Sander See footnotes | ARGS | Common Stock | I | 1.545.454 | 6.199.961 | ||||||
| 2016-08-04 | 2016-08-02 | 4 | Pharmstandard International S.A. | ARGS | Warrant to Purchase Common Stock | I | 5,50 | 1.772.727 | 1.772.727 | |||||
| 2016-08-04 | 2016-08-02 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 2.363.636 | 12.811.020 | ||||||
| 2016-08-04 | 2016-08-02 | 4 | ForArgos B.V. | ARGS | Common Stock Warrants (right to buy) | D | 5,50 | 1.159.090 | 1.159.090 | |||||
| 2016-08-04 | 2016-08-02 | 4 | ForArgos B.V. | ARGS | Common Stock | D | 1.545.454 | 3.749.817 | ||||||
| 2016-07-13 | 2016-07-11 | 4 | Katz Richard D | ARGS | Stock Option (right to buy) | D | 6,30 | 300.000 | 300.000 | |||||
| 2016-07-12 | 2016-07-11 | 4 | ALLEN LEE F MD PhD | ARGS | Stock Option (right to buy) | D | 6,30 | 83.373 | 83.373 | |||||
| 2016-07-05 | 2016-06-30 | 4 | Birner Hubert | ARGS | Common Stock | D | 2.854 | 5.588 | ||||||
| 2016-07-05 | 2016-06-30 | 4 | van Deventer Sander | ARGS | Common Stock | D | 1.427 | 2.794 | ||||||
| 2016-07-05 | 2016-06-30 | 4 | Petrov Andrei Vladimirovich | ARGS | Common Stock | D | 1.733 | 8.393 | ||||||
| 2016-07-05 | 2016-06-30 | 4 | Carey Robert | ARGS | Common Stock | D | 1.835 | 3.592 | ||||||
| 2016-07-05 | 2016-06-30 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 1.835 | 48.692 | ||||||
| 2016-07-05 | 2016-06-30 | 4 | Krol Igor | ARGS | Common Stock | D | 329 | 329 | ||||||
| 2016-07-01 | 2016-06-29 | 4 | Birner Hubert | ARGS | Common Stock Warrants (right to buy) | I | 5,35 | 206.659 | 206.659 | |||||
| 2016-07-01 | 2016-06-29 | 4 | Birner Hubert | ARGS | Common Stock | I | 275.545 | 1.930.333 | ||||||
| 2016-07-01 | 2016-06-29 | 4 | van Deventer Sander See footnotes | ARGS | Common Stock Warrants (right to buy) | I | 5,35 | 991.964 | 991.964 | |||||
| 2016-07-01 | 2016-06-29 | 4 | van Deventer Sander See footnotes | ARGS | Common Stock | I | 1.322.618 | 4.654.507 | ||||||
| 2016-07-01 | 2016-06-29 | 4 | Pharmstandard International S.A. | ARGS | Warrant to Purchase Common Stock | I | 5,35 | 2.008.726 | 2.008.726 | |||||
| 2016-07-01 | 2016-06-29 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 2.678.301 | 10.447.384 | ||||||
| 2016-07-01 | 2016-06-29 | 4 | ForArgos B.V. | ARGS | Common Stock Warrants (right to buy) | D | 5,35 | 991.964 | 991.964 | |||||
| 2016-07-01 | 2016-06-29 | 4 | ForArgos B.V. | ARGS | Common Stock | D | 1.322.618 | 2.204.363 | ||||||
| 2016-06-15 | 2016-06-13 | 4/A | Winterbottom Joan | ARGS | Common Stock | D | 9.075 | 42.784 | ||||||
| 2016-06-15 | 2016-06-13 | 4 | Harrelson Lori R. | ARGS | Stock Option (right to buy) | D | 7,41 | 40.000 | 40.000 | |||||
| 2016-06-15 | 2016-06-13 | 4 | Abbey Jeffrey D | ARGS | Stock Option (right to buy) | D | 7,41 | 250.000 | 250.000 | |||||
| 2016-06-15 | 2016-06-13 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 10.924 | 109.620 | ||||||
| 2016-06-15 | 2016-06-13 | 4 | Winterbottom Joan | ARGS | Stock Option (right to buy) | D | 7,41 | 80.000 | 80.000 | |||||
| 2016-06-15 | 2016-06-13 | 4 | Winterbottom Joan | ARGS | Common Stock | D | 7.287 | 40.996 | ||||||
| 2016-06-14 | 2016-06-13 | 4 | Birner Hubert | ARGS | Stock Option (right to buy) | D | 7,41 | 5.500 | 5.500 | |||||
| 2016-06-14 | 2016-06-13 | 4 | van Deventer Sander | ARGS | Stock Option (right to buy) | D | 7,41 | 5.500 | 5.500 | |||||
| 2016-06-14 | 2016-06-13 | 4 | Nicolette Charles A. | ARGS | Stock Option (right to buy) | D | 7,41 | 175.000 | 175.000 | |||||
| 2016-06-14 | 2016-06-13 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | 10.924 | 76.043 | ||||||
| 2016-06-14 | 2016-06-10 | 4 | Nicolette Charles A. | ARGS | Stock Option (right to buy) | D | 6,09 | 3.375 | 3.375 | |||||
| 2016-06-14 | 2016-06-13 | 4 | Petrov Andrei Vladimirovich | ARGS | Stock Option (right to buy) | D | 7,41 | 5.500 | 5.500 | |||||
| 2016-06-14 | 2016-06-13 | 4 | Carey Robert | ARGS | Stock Option (right to buy) | D | 7,41 | 5.500 | 5.500 | |||||
| 2016-06-14 | 2016-06-13 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Stock Option (right to buy) | D | 7,41 | 5.500 | 5.500 | |||||
| 2016-06-14 | 2016-06-10 | 4 | Krol Igor | ARGS | Stock Option (right to buy) | D | 7,41 | 11.000 | 11.000 | |||||
| 2016-04-19 | 2016-04-15 | 4 | ALLEN LEE F MD PhD | ARGS | Stock Option (right to buy) | D | 10,97 | 16.628 | 16.628 | |||||
| 2016-04-04 | 2016-03-31 | 4 | Birner Hubert | ARGS | Common Stock | D | 2.734 | 2.734 | ||||||
| 2016-04-04 | 2016-03-31 | 4 | van Deventer Sander | ARGS | Common Stock | D | 1.367 | 1.367 | ||||||
| 2016-04-04 | 2016-03-31 | 4 | Vinogradov Alexey Alexandrovich | ARGS | Common Stock | D | 1.367 | 3.367 | ||||||
| 2016-04-04 | 2016-03-31 | 4 | Petrov Andrei Vladimirovich | ARGS | Common Stock | D | 1.660 | 6.660 | ||||||
| 2016-04-04 | 2016-03-31 | 4 | Carey Robert | ARGS | Common Stock | D | 1.757 | 1.757 | ||||||
| 2016-04-04 | 2016-03-31 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 1.757 | 46.857 | ||||||
| 2016-03-16 | 3 | ForArgos B.V. | ARGS | Common Stock | D | 1.763.490 | ||||||||
| 2016-03-16 | 3 | ForArgos B.V. | ARGS | Common Stock | D | 1.763.490 | ||||||||
| 2016-03-16 | 2016-03-14 | 4 | Birner Hubert | ARGS | Common Stock Warrants (right to buy) | I | 5,35 | 137.773 | 137.773 | |||||
| 2016-03-16 | 2016-03-14 | 4 | Birner Hubert | ARGS | Common Stock | I | 183.697 | 1.654.788 | ||||||
| 2016-03-16 | 2016-03-14 | 4 | van Deventer Sander See footnotes | ARGS | Common Stock Warrants (right to buy) | I | 5,35 | 661.309 | 661.309 | |||||
| 2016-03-16 | 2016-03-14 | 4 | van Deventer Sander See Footnotes | ARGS | Common Stock | I | 881.745 | 3.331.889 | ||||||
| 2016-03-16 | 2016-03-14 | 4 | Pharmstandard International S.A. | ARGS | Warrant to Purchase Common Stock | I | 5,35 | 1.339.151 | 1.339.151 | |||||
| 2016-03-16 | 2016-03-14 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 1.785.534 | 7.769.083 | ||||||
| 2016-01-20 | 2016-01-19 | 4 | ALLEN LEE F MD PhD | ARGS | Stock Option (right to buy) | D | 2,16 | 300.000 | 300.000 | |||||
| 2016-01-12 | 2016-01-08 | 4 | Winterbottom Joan | ARGS | Common Stock | D | 32.709 | 33.709 | ||||||
| 2016-01-12 | 2016-01-08 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | 48.604 | 63.117 | ||||||
| 2016-01-12 | 2016-01-08 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 90.401 | 96.694 | ||||||
| 2016-01-12 | 2016-01-08 | 4 | Harrelson Lori R. | ARGS | Common Stock | D | 28.125 | 30.005 | ||||||
| 2016-01-12 | 2016-01-08 | 4 | MIESOWICZ FREDERICK | ARGS | Common Stock | D | 35.554 | 36.843 | ||||||
| 2016-01-08 | 2015-12-14 | 4/A | Abbey Jeffrey D By IRA | ARGS | Common Stock | I | 2,4972 | 5.000 | 12 | 11.500 | ||||
| 2015-12-17 | 2015-12-16 | 4 | Petrov Andrei Vladimirovich | ARGS | Common Stock | D | 1,8000 | 5.000 | 9 | 5.000 | ||||
| 2015-12-17 | 2015-12-16 | 4 | Winterbottom Joan By Trust | ARGS | Common Stock | I | 1,8300 | 250 | 0 | 500 | ||||
| 2015-12-17 | 2015-12-14 | 4 | Abbey Jeffrey D By IRA | ARGS | Common Stock | I | 2,4972 | 5.000 | 12 | 10.500 | ||||
| 2015-12-16 | 2015-12-15 | 4 | Vinogradov Alexey Alexandrovich | ARGS | Common Stock | D | 2,1500 | 2.000 | 4 | 2.000 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Winterbottom Joan By Trust | ARGS | Common Stock | I | 2,1492 | 50 | 0 | 250 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Winterbottom Joan By Trust | ARGS | Common Stock | I | 2,1450 | 100 | 0 | 200 | ||||
| 2015-12-16 | 2015-12-14 | 4 | Winterbottom Joan By Trust | ARGS | Common Stock | I | 2,1458 | 100 | 0 | 100 | ||||
| 2015-12-03 | 2015-12-02 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 3,8894 | 1.000 | 4 | 6.293 | ||||
| 2015-11-25 | 2015-11-24 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 4,2500 | 5.000 | 21 | 45.100 | ||||
| 2015-11-25 | 2015-11-24 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 4,3000 | 5.000 | 22 | 40.100 | ||||
| 2015-11-23 | 2015-11-19 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 4,1511 | 10.000 | 42 | 35.100 | ||||
| 2015-11-23 | 2015-11-19 | 4 | Abbey Jeffrey D By IRA | ARGS | Common Stock | I | 4,0800 | 1.000 | 4 | 6.500 | ||||
| 2015-09-21 | 2015-09-18 | 4 | Winterbottom Joan | ARGS | Stock Option (Right to Buy) | D | 6,21 | 20.000 | 20.000 | |||||
| 2015-09-04 | 2015-09-03 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 6,3072 | 6.000 | 38 | 25.100 | ||||
| 2015-09-04 | 2015-09-02 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 6,2236 | 6.000 | 37 | 19.100 | ||||
| 2015-09-02 | 2015-09-01 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 6,2636 | 5.000 | 31 | 13.100 | ||||
| 2015-08-27 | 2015-08-20 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 5,8047 | 5.000 | 29 | 8.100 | ||||
| 2015-08-27 | 2015-08-19 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Common Stock | D | 4,7272 | 3.100 | 15 | 3.100 | ||||
| 2015-08-27 | 2015-08-24 | 4 | Winterbottom Joan | ARGS | Common Stock | D | 6,0900 | 100 | 1 | 1.000 | ||||
| 2015-08-27 | 2015-08-24 | 4 | Winterbottom Joan | ARGS | Common Stock | D | 6,1000 | 900 | 5 | 900 | ||||
| 2015-08-27 | 2015-08-20 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | 6,4500 | 5.000 | 32 | 13.130 | ||||
| 2015-08-26 | 2015-08-25 | 4 | Lamarre Jean | ARGS | Common Stock | D | 6,1411 | 2.500 | 15 | 2.500 | ||||
| 2015-08-21 | 2015-08-19 | 4 | Abbey Jeffrey D By IRA | ARGS | Common Stock | I | 4,7544 | 5.500 | 26 | 5.500 | ||||
| 2015-06-19 | 2015-06-17 | 4/A | Underdown Brian J. | ARGS | Stock Option (right to buy) | D | 7,80 | 5.500 | 5.500 | |||||
| 2015-06-19 | 2015-06-17 | 4 | MIESOWICZ FREDERICK | ARGS | Stock Option (right to buy) | D | 7,80 | 20.000 | 20.000 | |||||
| 2015-06-19 | 2015-06-17 | 4 | Birner Hubert | ARGS | Stock Option (right to buy) | D | 7,80 | 5.500 | 5.500 | |||||
| 2015-06-19 | 2015-06-17 | 4 | Plessinger Douglas C. | ARGS | Stock Option (right to buy) | D | 7,80 | 30.000 | 30.000 | |||||
| 2015-06-19 | 2015-06-17 | 4 | Harrelson Lori R. | ARGS | Stock Option (right to buy) | D | 7,80 | 20.000 | 20.000 | |||||
| 2015-06-19 | 2015-06-17 | 4 | Abbey Jeffrey D | ARGS | Stock Option (right to buy) | D | 7,80 | 120.000 | 120.000 | |||||
| 2015-06-19 | 2015-06-17 | 4 | van Deventer Sander | ARGS | Stock Option (right to buy) | D | 7,80 | 5.500 | 5.500 | |||||
| 2015-06-19 | 2015-06-17 | 4 | Nicolette Charles A. | ARGS | Stock Option (right to buy) | D | 7,80 | 75.000 | 75.000 | |||||
| 2015-06-19 | 2015-06-17 | 4 | Lamarre Jean | ARGS | Stock Option (right to buy) | D | 7,80 | 5.500 | 5.500 | |||||
| 2015-06-19 | 2015-06-17 | 4 | Vinogradov Alexey Alexandrovich | ARGS | Stock Option (right to buy) | D | 7,80 | 5.500 | 5.500 | |||||
| 2015-06-19 | 2015-06-17 | 4 | Petrov Andrei Vladimirovich | ARGS | Stock Option (right to buy) | D | 7,80 | 5.500 | 5.500 | |||||
| 2015-06-19 | 2015-06-17 | 4 | Van Holle Philippe Marie Marcel Joseph | ARGS | Stock Option (right to buy) | D | 7,80 | 5.500 | 5.500 | |||||
| 2015-06-18 | 2015-06-17 | 4 | Underdown Brian J. | ARGS | Stock Option (right to buy) | D | 7,80 | 5.500 | 16.500 | |||||
| 2014-07-30 | 2014-07-28 | 4 | MIESOWICZ FREDERICK | ARGS | Stock Option (right to buy) | D | 6,09 | 10.200 | 185.075 | |||||
| 2014-07-30 | 2014-07-28 | 4 | Plessinger Douglas C. | ARGS | Stock Option (right to buy) | D | 6,09 | 10.200 | 185.076 | |||||
| 2014-07-30 | 2014-07-28 | 4 | Harrelson Lori R. | ARGS | Stock Option (right to buy) | D | 6,09 | 10.200 | 128.239 | |||||
| 2014-07-30 | 2014-07-28 | 4 | Abbey Jeffrey D | ARGS | Stock Option (right to buy) | D | 6,09 | 58.400 | 687.960 | |||||
| 2014-07-30 | 2014-07-28 | 4 | Nicolette Charles A. | ARGS | Stock Option (right to buy) | D | 6,09 | 18.000 | 297.803 | |||||
| 2014-03-24 | 2014-03-20 | 4 | van Deventer Sander | ARGS | Stock Option (right to buy) | D | 11,09 | -11.000 | 11.000 | |||||
| 2014-03-24 | 2014-03-20 | 4 | Vinogradov Alexey Alexandrovich | ARGS | Stock Option (right to buy) | D | 11,09 | -11.000 | 11.000 | |||||
| 2014-02-12 | 2014-02-12 | 4 | MIESOWICZ FREDERICK | ARGS | Series E Preferred Stock | D | -4.941 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | MIESOWICZ FREDERICK | ARGS | Series D Preferred Stock | D | -619 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | MIESOWICZ FREDERICK | ARGS | Series C Preferred Stock | D | -37 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | MIESOWICZ FREDERICK | ARGS | Common Stock | D | 4.941 | 5.597 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | MIESOWICZ FREDERICK | ARGS | Common Stock | D | 619 | 656 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | MIESOWICZ FREDERICK | ARGS | Common Stock | D | 37 | 37 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Birner Hubert | ARGS | Series E Preferred Stock | I | -663.082 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Birner Hubert | ARGS | Series D Preferred Stock | I | -665.583 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Birner Hubert | ARGS | Series C Preferred Stock | I | -94.351 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Birner Hubert | ARGS | Series B Preferred Stock | I | -8.202 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Birner Hubert | ARGS | Common Stock | I | 8,0000 | 39.873 | 319 | 1.471.091 | ||||
| 2014-02-12 | 2014-02-12 | 4 | Birner Hubert | ARGS | Common Stock | I | 663.082 | 1.431.218 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Birner Hubert | ARGS | Common Stock | I | 665.583 | 768.136 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Birner Hubert | ARGS | Common Stock | I | 94.351 | 102.553 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Birner Hubert | ARGS | Common Stock | I | 8.202 | 8.202 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Underdown Brian J. See footnotes | ARGS | Series E Preferred Stock | I | -569.990 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Underdown Brian J. See footnotes | ARGS | Series D Preferred Stock | I | -582.769 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Underdown Brian J. See footnotes | ARGS | Series C Preferred Stock | I | -43.185 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Underdown Brian J. See footnotes | ARGS | Series B Preferred Stock | I | -13.131 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Underdown Brian J. See footnotes | ARGS | Common Stock | I | 8,0000 | 40.497 | 324 | 1.249.572 | ||||
| 2014-02-12 | 2014-02-12 | 4 | Underdown Brian J. See footnotes | ARGS | Common Stock | I | 569.990 | 1.209.075 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Underdown Brian J. See footnotes | ARGS | Common Stock | I | 582.769 | 639.085 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Underdown Brian J. See footnotes | ARGS | Common Stock | I | 43.185 | 56.316 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Underdown Brian J. | ARGS | Common Stock | I | 13.131 | 13.131 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Abbey Jeffrey D | ARGS | Series E Preferred Stock | D | -1.267 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Abbey Jeffrey D | ARGS | Series D Preferred Stock | D | -1.238 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Abbey Jeffrey D | ARGS | Series C Preferred Stock | D | -75 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 1.267 | 2.580 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 1.238 | 1.313 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Abbey Jeffrey D | ARGS | Common Stock | D | 75 | 75 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | van Deventer Sander See footnotes | ARGS | Series E Preferred Stock | I | -1.428.888 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | van Deventer Sander See footnotes | ARGS | Series D Preferred Stock | I | -984.840 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | van Deventer Sander See footnotes | ARGS | Common Stock | I | 8,0000 | 36.416 | 291 | 2.450.144 | ||||
| 2014-02-12 | 2014-02-12 | 4 | van Deventer Sander See footnotes | ARGS | Common Stock | I | 1.428.888 | 2.413.728 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | van Deventer Sander See footnotes | ARGS | Common Stock | I | 984.840 | 984.840 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Nicolette Charles A. | ARGS | Series E Preferred Stock | D | -1.859 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Nicolette Charles A. | ARGS | Series D Preferred Stock | D | -4.941 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | 1.859 | 6.800 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Nicolette Charles A. | ARGS | Common Stock | D | 4.941 | 4.941 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Cooperatieve AAC LS U.A. See footnotes | ARGS | Series E Preferred Stock | I | -1.428.888 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Cooperatieve AAC LS U.A. See footnotes | ARGS | Series D Preferred Stock | I | -984.840 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Cooperatieve AAC LS U.A. See footnotes | ARGS | Common Stock | I | 8,0000 | 36.416 | 291 | 2.450.144 | ||||
| 2014-02-12 | 2014-02-12 | 4 | Cooperatieve AAC LS U.A. See footnotes | ARGS | Common Stock | I | 1.428.888 | 2.413.728 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Cooperatieve AAC LS U.A. See footnotes | ARGS | Common Stock | I | 984.840 | 984.840 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Pharmstandard International S.A. | ARGS | Series E Preferred Stock | I | -4.708.549 | 0 | ||||||
| 2014-02-12 | 2014-02-12 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 8,0000 | 1.275.000 | 10.200 | 5.983.549 | ||||
| 2014-02-12 | 2014-02-12 | 4 | Pharmstandard International S.A. | ARGS | Common Stock | I | 4.708.549 | 4.708.549 | ||||||
| 2014-02-06 | 3 | Kyowa Hakko Kirin Co Ltd | ARGS | Common Stock | D | 140.812 | ||||||||
| 2014-02-06 | 3 | Kyowa Hakko Kirin Co Ltd | ARGS | Common Stock | D | 140.812 | ||||||||
| 2014-02-06 | 3 | Mizuho Capital No. 3 Limited Partnership | ARGS | Common Stock | D | 86.650 | ||||||||
| 2014-02-06 | 3 | Mizuho Capital No. 3 Limited Partnership | ARGS | Common Stock | D | 86.650 | ||||||||
| 2014-02-06 | 3 | TFG USA, LLC | ARGS | Common Stock | D | 72.366 | ||||||||
| 2014-02-06 | 3 | TFG USA, LLC | ARGS | Common Stock | D | 72.366 | ||||||||
| 2014-02-06 | 3 | Vinogradov Alexey Alexandrovich | ARGS | No securities are beneficially owned | D | 0 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
